Synthesis and biological activity of 3-substituted 3-desoxynaltrindole derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 7, 1998, Pages 799-804

  Kubota, Hitoshi ^a   Rothman, Richard B ^b   Dersch, Chris ^b   McCullough, Karen ^b   Pinto, Julia ^a   Rice, Kenner C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NIDA Addiction Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; KAPPA OPIATE RECEPTOR; NALTREXONE; NALTRINDOLE; NALTRINDOLE DERIVATIVE; OPIATE ANTAGONIST; OPIATE RECEPTOR; U 690593; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GUINEA PIG; NONHUMAN; RAT;

ANIMALS; BENZENEACETAMIDES; BINDING, COMPETITIVE; BRAIN; CELL MEMBRANE; DRUG DESIGN; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, LEUCINE-2-ALANINE; ENKEPHALINS; MOLECULAR STRUCTURE; NALTREXONE; NARCOTIC ANTAGONISTS; PYRROLIDINES; RATS; RECEPTORS, OPIOID, DELTA; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0000795161     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00105-X     Document Type: Article

References (31)

1. (1) Reisine, T. Neuropharmacology 1995, 34, 463.
2. (2) Goldstein, A.; Naidu, A. Mol. Pharmacol. 1989, 36, 265.
3. (3) Mansour, A.; Fox, C. A.; Akil, H.; Watson, S. J. Trends Neurosci. 1995, 18, 22.
4. (4) Reid, L. D.; Hubbell, C. L.; Glaccum, M. B.; Bilsky, E. J.; Portoghese, P. S.; Porreca, F. Life Sci. 1993, 52, PL67.
5. (5) Abdelhamid, E. E.; Sultana, M.; Portoghese, P. S.; Takemori, A. E. J. Pharmacol. Exp. Ther. 1991, 258, 299.
6. (6) Cowan, A.; Zhu, X. Z.; Mosberg, H. I.; Omnaas, J. R.; Porreca, F. J. Pharmacol. Exp. Ther. 1988, 246, 950.
7. (7) Cheng, P. Y.; Wu, D.; Decena, J.; Soong, Y.; McCabe, S.; Szeto, H. H. Eur. J. Pharmacol. 1993, 267, 852.
8. (8) Galligan, J. J.; Mosberg, H. I.; Hurst, R.; Hruby, V. J.; Burks, T. F. J. Pharmacol. Exp. Ther. 1984, 229, 641.
9. (9) Fundytus, M. E.; Schiller, P. W.; Shapiro, M.; Weltrowska, G.; Coderre, T. J. Regul Pept 1994, 54, 97.
10. (10) Portoghese, P. S.; Sultana, M.; Nagase, H.; Takemori, A. E. J. Med. Chem. 1988, 31, 281.
11. (11) Takemori, A. E.; Sultana, M.; Nagase, H.; Portoghese, P. S. Life Sci. 1992, 50, 1491.
12. (12) Schwyzer, R. Ann. N. Y. Acad. Sci. 1977, 297, 3.
13. (13) Chavkin, C.; Goldstein, A. Proc. Natl. Acad. Sci. U.S.A. 1981, 78, 6543.
14. (14) Portoghese, P. S.; Sultana, M.; Takemori, A. E. J. Med. Chem. 1990, 33, 1714.
15. (15) Portoghese, P. S.; Sultana, M.; Takemori, A. E. J. Med. Chem. 1990, 33, 1547.
16. (16) Maguire, P. A.; Perez, J. J.; Tsai, N. F.; Rodriguez, L.; Beatty, M. F.; Villar, H. O.; Kamal, J. J.; Upton, C.; Casy, A. F.; Loew, G. H. Mol Pharmacol 1993, 44, 1246.
17. (17) Portoghese, P. S.; Sultana, M.; Moe, S. T.; Takemori, A. E. J Med Chem 1994, 37, 579.
18. (18) Schmidhammer, H.; Daurer, D.; Wieser, M.; Monory, K.; Borsodi, A.; Elliott, J.; Traynor, J. R. Bioorg. Med. Chem. Lett. 1997, 7, 151.
19. (19) All new compounds have physical and spectroscopic data fully consistent with the assigned structures.
20. (20) Saá, J. M.; Dopico, M.; Martorell, G.; García-Raso, A. J. Org. Chem. 1990, 55, 991.
21. (21) Hedberg, M. H.; Johansson, A. H.; Hacksell, U. J. Chem. Soc., Chem. Commun. 1992, 845.
22. (22) Martorell, G.; García-Raso, A.; Saá, J. M. Tetrahedron Lett. 1990, 31, 2357.
23. (23) Saá, J. M.; Martorell, G.; García-Raso, A. J. Org. Chem. 1992, 57, 678.
24. (24) The conditions reported by Echavarren, A. M.; Stille, J. K. (J. Am. Chem. Soc. 1987, 109, 5478) gave 5 in 51% yield with 25% recovery of 3.
25. (25) Huth, A.; Beetz, I.; Schumann, I. Tetrahedron 1989, 45, 6679.
26. (26) Fu, J.-m.; Snieckus, V. Tetrahedron Lett. 1990, 31, 1665.
27. (27) Hedberg, M. H.; Johansson, A. M.; Fowler, C. J.; Terenius, L.; Hacksell, U. Bioorg. Med. Chem. Lett. 1994, 4, 2527.
28. (28) Rice, K. C. J. Med. Chem. 1977, 20, 164.
29. (29) Rothman, R. B.; Xu, H.; Seggel, M.; Jacobson, A. E.; Rice, K. C.; Brine, G. A.; Carroll, F. I. Life Sci. 1991, 48, PL111.
30. (30) Xu, H.; Partilla, J. S.; de Costa, B. R.; Rice, K. C.; Rothman, R. B. Peptides 1992, 13, 1207.
31. (31) Lahti, R. A.; Mickelson, M. S.; McCall, J. M.; von Voightlander, P. F. Eur. J. Pharmacol. 1985, 109, 281.